You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-ATRX antibody (ab54794)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-ATRX antibody
See all ATRX products (6) ...

Description

Mouse monoclonal to ATRX

Tested applications

WBmore details

Cross reactivity

Reacts with

Recombinant Fragment

Predicted to work with

Human

Immunogen

Recombinant fragment: FNLGALSAMS NQQLEDLINQ GREKVVEATN SVTAVRIQPL EDIISAVWKE NMNLSEAQVQ ALALSRQASQ ELDVKRREAI YNDVLTKQQM LISCVQRILM , corresponding to amino acids 2311-2411 of Human ATRX

FNLGALSAMS NQQLEDLINQ GREKVVEATN SVTAVRIQPL EDIISAVWKE NMNLSEAQVQ ALALSRQASQ ELDVKRREAI YNDVLTKQQM LISCVQRILM

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
PBS, pH 7.2

Concentration

Concentration information loading...

Purity

Protein G purified

Clonality

Monoclonal

Isotype

IgG1

Light chain type

kappa

  • Western blot - ATRX antibody (ab54794)Western blot - ATRX antibody (ab54794) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab54794 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

WB: Use at a concentration of 1-5 µg/ml.

This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Could be a global transcriptional regulator. Modifies gene expression by affecting chromatin. May be involved in brain development and facial morphogenesis.

Tissue specificity

Ubiquitous.

Involvement in disease

Defects in ATRX are the cause of alpha-thalassemia mental retardation syndrome X-linked non-deletion type (ATRX) [MIM:301040]. ATR-X is an X-linked disorder comprising severe psychomotor retardation, facial dysmorphism, urogenital abnormalities, and alpha-thalassemia. An essential phenotypic trait are hemoglobin H erythrocyte inclusions.
Defects in ATRX are the cause of mental retardation syndromic X-linked with hypotonic facies syndrome type 1 (MRXSHF1) [MIM:309580]; also called Carpenter-Waziri syndrome (CWS), Juberg-Marsidi syndrome (JMS), Smith-Fineman-Myers syndrome type 1 (SFM1). Clinical features include severe mental retardation, dysmorphic facies, and a highly skewed X-inactivation pattern in carrier women. Other more variable features include hypogonadism, deafness, renal anomalies, and mild skeletal defects.
Defects in ATRX are a cause of alpha-thalassemia myelodysplasia syndrome (ATMDS) [MIM:300448]. In this disorder, alpha-thalassemia occurs as an acquired abnormality in association with a multilineage myelodysplasia.

Sequence similarities

Belongs to the SNF2/RAD54 helicase family.
Contains 1 ADD domain.
Contains 1 GATA-type zinc finger.
Contains 1 helicase ATP-binding domain.
Contains 1 helicase C-terminal domain.
Contains 1 PHD-type zinc finger.

Domain

Contains one Pro-Xaa-Val-Xaa-Leu (PxVxL) motif, which is required for interaction with chromoshadow domains. This motif requires additional residues -7, -6, +4 and +5 of the central Val which contact the chromoshadow domain.

Post-translational
modifications

Phosphorylated upon DNA damage, probably by ATM or ATR.

Cellular localization

Nucleus. Associated with pericentromeric heterochromatin during interphase and mitosis, probably by interacting with HP1.

Target information above from: UniProt accessionP46100 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Alpha thalassemia/mental retardation syndrome X linked homolog antibody
  • alpha thalassemia/mental retardation syndrome X-linked homolog antibody
  • ATP dependent helicase ATRX antibody
  • ATP-dependent helicase ATRX antibody
  • ATR2 antibody
  • Atrx antibody
  • ATRX_HUMAN antibody
  • DNA dependent ATPase and helicase antibody
  • Helicase 2, X linked antibody
  • MGC2094 antibody
  • RAD54 antibody
  • RAD54L antibody
  • SFM1 antibody
  • SHS antibody
  • Transcriptional regulator ATRX antibody
  • X linked helicase II antibody
  • X linked nuclear protein antibody
  • X-linked helicase II antibody
  • X-linked nuclear protein antibody
  • XH2 antibody
  • XNP antibody
  • Znf HX antibody
  • Znf-HX antibody
see all

Anti-ATRX antibody images:

  Western blot - ATRX antibody (ab54794)

Western blot - ATRX antibody (ab54794)

Western blot against tagged recombinant protein immunogen using ab54794 ATRX antibody at 1ug/ml. Predicted band size of immunogen is 38 kDa.

This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.

References for Anti-ATRX antibody (ab54794)

ab54794 has not yet been referenced specifically in any publications.

Publishing research using ab54794? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"